Pet technology
Predicting 90% Response: Pet Technology Brain PET vs PET
In 2023, a multicenter trial showed that multitracer PET can predict amyloid-β therapy response with 90% accuracy, giving clinicians a reliable early-stage decision tool. This level of confidence comes from combining high-resolution imaging with adaptive sensor data, allowing a single scan to guide treatment pathways. Imagine prescribing an amyloid-β therapy